GlassScriptPhysician profile
David Joseph Mcelligott
NPI 1578579850
$6,351.24
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,563 · 2020: $1,575 · 2021: $213.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $2,872.38 | 2019 | |
| Glaxosmithkline, LLC. | $787.05 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $779.62 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $643.83 | 2019-2021 | |
| Mylan Specialty L.P. | $433.56 | 2019-2020 | |
| Genentech USA, INC. | $195.51 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $111.60 | 2019-2020 | |
| Electromed, INC. | $96.52 | 2019 | |
| Jazz Pharmaceuticals INC. | $72.15 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $65.28 | 2019-2020 | |
| Advanced Respiratory, INC | $56.83 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $47.20 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.25 | 2020 | |
| Philips North America LLC | $32.51 | 2019 | |
| Amgen INC. | $24.31 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $23.93 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.25 | 2019 | |
| Shire North American Group INC | $19.26 | 2019 | |
| Bard Peripheral Vascular, INC. | $15.95 | 2019 | |
| Mayne Pharma Commercial LLC | $15.25 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mcelligott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.